Conti C Richard
University of Florida, Health Science Center, Room M-438, 1600 SW Archer Road, Gainesville, 32610-0277, USA.
Curr Cardiol Rep. 2006 Jul;8(4):272-6. doi: 10.1007/s11886-006-0058-2.
Patients with refractory angina are those for whom medical therapy has failed to eradicate the angina completely and who have persistent symptoms that are stable but limit their activities of daily living. Approach to management must include the elimination of the secondary causes of this condition and maximum medical therapy, and if angina persists, the consideration of other strategies. Controversy exists regarding the value of transmural myocardial laser revascularization. Enhanced external counterpulsation is clinically effective in approximately 70% of patients. Spinal cord stimulation is not being used clinically in the United States. In the United States, it is still an investigational procedure that is currently being evaluated prospectively in a randomized trial. Ranolazine, an inhibitor of sodium-dependent calcium overload, may prove to be useful in patients with refractory angina.
难治性心绞痛患者是指那些药物治疗未能完全消除心绞痛且持续存在稳定症状但限制其日常生活活动的患者。治疗方法必须包括消除该病症的继发原因和进行最大程度的药物治疗,若心绞痛持续存在,则应考虑其他策略。关于透壁心肌激光血运重建术的价值存在争议。增强型体外反搏在约70%的患者中临床有效。脊髓刺激在美国尚未应用于临床。在美国,它仍是一种研究性手术,目前正在一项随机试验中进行前瞻性评估。雷诺嗪,一种钠依赖性钙超载抑制剂,可能被证明对难治性心绞痛患者有用。